News for Sosei Group Corporation (4565.T)

Published at

Oct 9, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight

The rise in research and development activities in schizophrenia treatment is driving market growth by fostering the development of innovative therapies,...

SOLTF INTO 4565.T ATAI

Read more →
Published at

Apr 11, 2024 2:37 PM

by europeanbusinessreview.com

positive

positive

Aligning Organisational Ecosystems to be Fit for Purpose

By Jonathan Trevor and Kazuhiro Asakawa In the first of a two-part series, we explore how firms are reaping the benefits of leveraging a network of external resources for enhanced […]

SOLTF 4565.T

Read more →
Published at

Apr 1, 2024 6:00 AM

by marketscreener.com

positive

positive

Sosei Group Corporation will Change its Name to Nxera Pharma Co., Ltd

Effective April 01, 2024, Sosei Group Corporation will change its name to Nxera Pharma Co., Ltd....

SOLTF 4565.T

Read more →
Published at

Mar 27, 2024 7:56 AM

by investing.com

neutral

neutral

Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma By Investing.com

Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma

SOLTF 4565.T

Read more →
Published at

Mar 11, 2024 7:38 AM

by globenewswire.com

positive

positive

Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of schizophrenia

Single-target agreement focused on development of novel, small molecule agonists of GPR52 discovered by Sosei Heptares with the potential to simultaneously...

SOLTF 4565.T

Read more →
Published at

Mar 6, 2024 8:00 AM

by globenewswire.com

mixed

mixed

Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals

Tokyo, Japan and Cambridge, UK, 6 March 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) announces that Formosa...

4746.TW SOLTF 4565.T

Read more →
Published at

Jan 22, 2024 10:30 AM

by globenewswire.com

neutral

neutral

Sosei Heptares Webinar Presentation for FY2023 Financial Results

Tokyo, Japan and Cambridge, UK, 22 January 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) will announce its earnings results...

SOLTF 4565.T

Read more →
Published at

Jan 5, 2024 9:00 AM

by globenewswire.com

positive

positive

Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer

Tokyo, Japan and Cambridge, UK, 5 January 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) today announces the appointment of...

SOLTF 4565.T

Read more →
Published at

Dec 26, 2023 6:10 AM

by marketscreener.com

positive

positive

Sosei : Shared Research, Inc. Issued an Analyst Report on Sosei Group Corporation -December 26, 2023 at 12:10 am EST

Shared Research, Inc. Issued an Analyst Report on Sosei Group Corporation Attachments Original Link Original Document ...

SOLTF 4565.T

Read more →
Published at

Dec 21, 2023 9:23 AM

by globenewswire.com

neutral

neutral

Sosei Heptares to Present at 42nd Annual J.P. Morgan Healthcare Conference

Tokyo, Japan and Cambridge, UK, 21 December 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), announces its President &...

SOLTF 4565.T

Read more →
Published at

Jul 12, 2023 9:40 PM

by valuewalk.com

mixed

mixed

Automakers Among Most Shorted Securities In Americas In June

The report is a monthly listing of the top 10 most shorted securities in the Americas, EMEA and APAC regions in the large-, mid-, and small-cap exchanges.

ZZA.DE TSLAD.BA TSLAC.BA TSLA34.SA TSLA.MX TSLA TL0.DE SOFI.MX SOBKY SFBQF NLLSY NLLSF NELO.OL NEL.OL F CNK.MX CNK CAJFF CAJ AOMFF AOMD.DE ALSMY ALONV.PA ALO.PA 9984.T 9434.T 7751.T 6753.T 6594.T PEB-PH PEB FSR DDD BRG.AX 8698.T 4565.T 4180.T 2412.T

Read more →
Published at

Feb 6, 2023 1:30 PM

by prnewswire.com

mixed

mixed

Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides Financial Expectations for 2023

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...

DNL.L XENE TKPHF TAKP34.SA TAKN.MX TAK SOLTF NBIX 4565.T 4502.T 4502.S 0K6R.L 0A87.L VYGR.MX VYGR

Read more →
Published at

Feb 6, 2023 1:30 PM

by markets.businessinsider.com

mixed

mixed

Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides Financial Expectations for 2023

INGREZZA® (valbenazine) Fourth Quarter Net Product Sales of $399 MillionINGREZZA® (valbenazine) 2023 Net Product Sales Guidance of $1.67 - $1.77 B...

DNL.L XENE TKPHF TAKP34.SA TAKN.MX TAK SOLTF NBIX 4565.T 4502.T 4502.S 0K6R.L 0A87.L VYGR.MX VYGR

Read more →
Published at

Nov 1, 2022 12:30 PM

by prnewswire.com

mixed

mixed

Neurocrine Biosciences Reports Third Quarter 2022 Financial Results and Raises 2022 INGREZZA Sales Guidance

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended September 30, 2022 and raised net...

FRGAP DNL.L XENE TKPHF TAKP34.SA TAKN.MX TAK SOLTF NBIX 4565.T 4502.T 4502.S 0K6R.L 0A87.L

Read more →
Published at

Jan 6, 2021 7:58 AM

by rttnews.com

mixed

mixed

MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301

Today's Daily Dose brings you news about the FDA lifting the partial clinical hold on Marker Therapeutics' phase II post-transplant acute myeloid leukemia trial; Rhythm selling its Rare Pediatric Disease Priority Review Voucher for $100 million; Hoth Therapeutics' financing agreement; Millendo discontinuing further development of MLE-301 for the treatment of menopausal vasomotor symptoms.

RYTM MLND HOTH CERC C6K.F ARPO ABBV 3OS1.SG 3OS1.F 3OS1.BE 335.MU 335.F 335.BE 1RV.F SYN SFYC.F SFYC.BE MRSN IPA.V IPA ENSG EGB.F EGB.BE BNGO.MX BNGO 4565.T 2Y3.MU 2Y3.BE 0M4.F 0M4.BE

Read more →